about
Subgroups of chemotherapy patients with distinct morning and evening fatigue trajectories.Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapyPredictors and Trajectories of Morning Fatigue Are Distinct From Evening Fatigue.Trajectories of Evening Fatigue in Oncology Outpatients Receiving Chemotherapy.Associations between multiple chronic conditions and cancer-related fatigue: an integrative review.Self-management for adult patients with cancer: an integrative review.Congruence Between Latent Class and K-modes Analyses in the Identification of Oncology Patients with Distinct Symptom Experiences.Age differences in fatigue, decrements in energy, and sleep disturbance in oncology patients receiving chemotherapy.Common and Distinct Characteristics Associated With Trajectories of Morning and Evening Energy in Oncology Patients Receiving Chemotherapy.Gene Expression Profiling of Evening Fatigue in Women Undergoing Chemotherapy for Breast Cancer.The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy.Comparison of subgroups of breast cancer patients on pain and co-occurring symptoms following chemotherapy.Differential expression of genes and differentially perturbed pathways associated with very high evening fatigue in oncology patients receiving chemotherapy.Inflammatory pathway genes associated with inter-individual variability in the trajectories of morning and evening fatigue in patients receiving chemotherapy.Primer in Genetics and Genomics, Article 6: Basics of Epigenetic Control.Primer in Genetics and Genomics, Article 5-Further Defining the Concepts of Genotype and Phenotype and Exploring Genotype-Phenotype Associations.Maintaining Perioperative Normothermia: Sustaining an Evidence-Based Practice Improvement Project.Learning from data to predict future symptoms of oncology patientsNetwork Analysis of the Multidimensional Symptom Experience of OncologyRisk Factors Associated With Chemotherapy-Induced Nausea in the Week Before the Next Cycle and Impact of Nausea on Quality of Life OutcomesImplementation of Enhanced Recovery After Surgery in a Community Hospital: An Evidence-Based ApproachMorning Fatigue Severity Profiles in Oncology Outpatients Receiving ChemotherapyNeuropsychological Symptoms and Intrusive Thoughts Are Associated With Worse Trajectories of Chemotherapy-Induced NauseaDistinct Stress Profiles Among Oncology Patients Undergoing ChemotherapyIndividualized Fall Prevention Program in an Acute Care Setting: An Evidence-Based Practice ImprovementStability of Symptom Clusters in Patients With Lung Cancer Receiving ChemotherapySymptom Clusters in Patients With Gastrointestinal Cancers Using Different Dimensions of the Symptom ExperienceIdentification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptomsAlterations in Patterns of Gene Expression and Perturbed Pathways in the Gut-Brain Axis Are Associated With Chemotherapy-Induced NauseaGastrointestinal symptoms are associated with trajectories of chemotherapy-induced nauseaPsychological Symptoms and Stress Are Associated With Decrements in Attentional Function in Cancer Patients Undergoing Chemotherapy
P50
Q33808297-BDFE6ADF-D800-439A-8A62-453F31CE4D9AQ33940740-BCAB6F1E-5BCC-44BF-99E6-93F883109F68Q35920565-62AE6566-E55F-4B49-9006-462478CCDAABQ35920885-2F3DC155-B0E4-4256-B543-63BB904F884EQ38213602-DE380431-C405-4FEF-8113-A677031E2945Q38360260-385D271A-99AA-4228-864E-28C805EA940FQ38599341-AA9186BB-54BC-4B05-90B9-BD532D13E4A0Q38837991-7842F3C5-7335-4B3C-B9B8-F8DA38D32B0CQ39034195-13E6F382-F6CE-41DA-B408-0C2A85F2F1EEQ39937097-9D2EDA5B-74FA-4441-B567-278E65A22F83Q44076205-491DD364-DBF2-49E6-96B3-5E02E274A865Q46142043-E083B35D-2B5D-4EF5-BEA5-927F91ACA013Q46193738-4DC40B59-7EA1-40F8-8895-71D765042DBBQ46893422-96DB31F1-842C-4904-858F-D69C0533C509Q47371384-C941704A-2973-4D52-9D37-E829E2F5CF10Q48334444-6F8A369B-175C-465B-9399-0548E3F8E103Q53185597-ADB116CB-78BE-4536-B4B0-A85C80D438E8Q60924538-180192CA-7224-4262-9DE2-8CB73B99DC96Q64258059-AC92815F-2C72-4654-A0F4-763F473ACCB0Q88951005-EDC1B355-566A-4AE9-AC0A-39D952C491BDQ89157217-9BD18E96-BF4F-435D-A9E5-BB9C6BFC7D02Q90338770-B9F9696B-9001-4C0D-ACC6-ED62F15AE69FQ91123764-82B7B7F2-EF79-4ACF-A0C9-A5FDC98732DCQ91231526-D150E908-5447-4244-A3E5-0C4B54F5C82BQ91355251-B567B04E-B104-44CE-8DDC-7B32ABF9B269Q91622983-EFAB35B0-ACD2-427F-8A52-0E1B00F29E4FQ91942003-6F97287F-C44A-4A4D-8A89-62C816A872ACQ92287283-B74EDECD-F8B9-411E-9A38-F8104CF19B0FQ92555787-7CDD383D-7A37-4805-B4DC-F3EEC937243CQ92717999-6943CD2B-C12B-48C6-8606-651DD6B0D549Q93176777-26870197-74CA-4D7D-A323-3FEC3935B667
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Fay Wright
@en
Fay Wright
@nl
type
label
Fay Wright
@en
Fay Wright
@nl
prefLabel
Fay Wright
@en
Fay Wright
@nl
P31
P496
0000-0001-9636-0411